Literature DB >> 29062555

Synoptic Versus Narrative Reporting of Prostate Biopsies at a Tertiary Healthcare Institution: Challenges, successes and expectations.

Nnamdi O Orah1,2, Charles C Anunobi3, Rufus W Ojewola4.   

Abstract

OBJECTIVES: Cancer pathology reports are expected to contain all information required for patient management and disease surveillance. Moreover, reports for patients with prostate cancer have become increasingly complex with the addition of more pathological details. This study aimed to compare narrative and synoptic prostate cancer reports for core needle biopsies received at a tertiary hospital in Nigeria in order to determine which form was most complete according to international standards.
METHODS: This study was conducted from January 2010 to December 2015 at the Lagos University Teaching Hospital, Lagos, Nigeria. All malignant prostate cancer histopathology reports received during this period were analysed for the presence of important clinicopathological parameters, including the numbers of cores taken and those involved by the tumour, percentage of tumour involvement, Gleason score and the presence of high-grade prostatic intraepithelial neoplasms (HGPINs) and perineural and lymphovascular invasion.
RESULTS: A total of 83 reports were reviewed, of which 27 were in narrative and 56 in synoptic format. The documentation of clinicopathological characteristics in narrative reports was significantly incomplete compared to synoptic reports in recording the number of cores (33.3% versus 96.4%), number of cores involved by the tumour (11.1% versus 94.6%), percentage of cores involved by the tumour (3.7% versus 100.0%) and the presence of HGPINs (7.4% versus 100.0%) and perineural (59.3% versus 98.2%) and lymphovascular (48.1% versus 100.0%) invasion (P <0.001 each).
CONCLUSION: Synoptic reports of malignant prostate cancer biopsies received at the Lagos University Teaching Hospital were found to contain more complete information than narrative reports.

Entities:  

Keywords:  Biopsy; Nigeria; Pathology; Prostate Cancer; Prostatic Intraepithelial Neoplasia

Mesh:

Year:  2017        PMID: 29062555      PMCID: PMC5642362          DOI: 10.18295/squmj.2017.17.03.010

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  14 in total

Review 1.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Authors:  D G Bostwick; D J Grignon; M E Hammond; M B Amin; M Cohen; D Crawford; M Gospadarowicz; R S Kaplan; D S Miller; R Montironi; T F Pajak; A Pollack; J R Srigley; J W Yarbro
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 2.  Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.

Authors:  M J Barry
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

3.  Protocol for the examination of specimens from patients with carcinoma of the prostate gland.

Authors:  John R Srigley; Peter A Humphrey; Mahul B Amin; Sam S Chang; Lars Egevad; Jonathan I Epstein; David J Grignon; James M McKiernan; Rodolfo Montironi; Andrew A Renshaw; Victor E Reuter; Thomas M Wheeler
Journal:  Arch Pathol Lab Med       Date:  2009-10       Impact factor: 5.534

4.  Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.

Authors:  George J Netto; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2006-09       Impact factor: 6.394

5.  Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy.

Authors:  Kiaran J O'Malley; Charles R Pound; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Journal:  Urology       Date:  2002-01       Impact factor: 2.649

6.  Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.

Authors:  Stephen J Freedland; George S Csathy; Frederick Dorey; William J Aronson
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

7.  Making the most of your pathology: standardized histopathology reporting in head and neck cancer.

Authors:  Warren K Yunker; T Wayne Matthews; Joseph C Dort
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-02

8.  Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.

Authors:  Hsiang-Hsuan M Yu; Danny Y Song; Ya-Yu Tsai; Travis Thompson; Deborah A Frassica; Theodore L DeWeese
Journal:  Urology       Date:  2007-07       Impact factor: 2.649

9.  Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue.

Authors:  F Brimo; R T Vollmer; J Corcos; K Kotar; L R Bégin; P A Humphrey; T A Bismar
Journal:  Histopathology       Date:  2008-08       Impact factor: 5.087

10.  Standardized synoptic cancer pathology reporting: a population-based approach.

Authors:  John R Srigley; Tom McGowan; Andrea Maclean; Marilyn Raby; Jillian Ross; Sarah Kramer; Carol Sawka
Journal:  J Surg Oncol       Date:  2009-06-15       Impact factor: 3.454

View more
  2 in total

1.  Motivations and Barriers Toward Implementation of a Rectal Cancer Synoptic Operative Report: A Process Evaluation.

Authors:  Serena S Bidwell; Gabriela C Poles; Andrew A Shelton; Kristan Staudenmayer; Sylvia Bereknyei Merrell; Arden M Morris
Journal:  Dis Colon Rectum       Date:  2022-03-01       Impact factor: 4.585

2.  Establishing Synoptic Cancer Pathology Reporting in Low- and Middle-Income Countries: A Nicaraguan Experience.

Authors:  Darling Valverde L; Richard C Reznichek; Magdaly Torres S
Journal:  JCO Glob Oncol       Date:  2022-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.